Ignite Creation Date:
2025-12-25 @ 3:40 AM
Ignite Modification Date:
2025-12-26 @ 2:24 AM
Study NCT ID:
NCT00928902
Status:
COMPLETED
Last Update Posted:
2010-10-21
First Post:
2009-06-24
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Trial for the Evaluation of the Effect of Systemic Low-dose Interleukin-2 (IL-2) on the Immunogenicity of a Vaccine Comprising Synthetic Melanoma Peptides Administered With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With High Risk Melanoma
Sponsor:
University of Virginia
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
1999-11
Start Date Type:
None
Primary Completion Date:
2001-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-03
Completion Date Type:
ACTUAL
First Submit Date:
2009-06-24
First Submit QC Date:
None
Study First Post Date:
2009-06-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-10-20
Last Update Post Date:
2010-10-21
Last Update Post Date Type:
ESTIMATED